Aptus Capital Advisors’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,841
Closed -$177K 921
2022
Q4
$177K Sell
7,841
-63
-0.8% -$1.45K 0.01% 489
2022
Q3
$171K Buy
7,904
+131
+2% +$2.88K ﹤0.01% 458
2022
Q2
$161K Sell
7,773
-890
-10% -$19.9K ﹤0.01% 391
2022
Q1
$207K Buy
+8,663
New +$214K 0.01% 418

Other funds holding SENT

Aptus Capital Advisors's SENT Position: Q1 2023 in Review

Aptus Capital Advisors sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q1 2023, closing a stake of 7,841 shares — an estimated $177K sold.

Aptus Capital Advisors first reported a position in SENT in Q1 2022 and held it in 4 quarters. The position peaked at $207K in Q1 2022. 9 funds tracked by Wall St. Rank hold SENT as of Q1 2023.

  • Aptus Capital Advisors reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q1 2023 after selling out during the quarter.
  • Aptus Capital Advisors sold 7,841 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q1 2023, an estimated $177K.
  • Aptus Capital Advisors first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q1 2022 and held it in 4 quarters.
  • Aptus Capital Advisors's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $207K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q1 2023.

Based on Aptus Capital Advisors's 13F filing for Q1 2023, filed 9 May 2023.